Table 3.
The association of FSD with patient demographics, cardiovascular risk factors, clinical variables, and AGA
| Univariate analysis | Logistic regression analysis | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| OR | 95% CI | p value* | OR | 95% CI | p value* | |
| Age (years) | 1.17 | 1.12–1.22 | <0.001 | 1.21 | 1.13–1.30 | <0.001 |
| Height (cm) | 0.97 | 0.92–1.02 | 0.183 | |||
| Weight (kg) | 1.03 | 1.00–1.05 | 0.011 | |||
| Waist circumference | 1.05 | 1.02–1.07 | <0.001 | |||
| Hip circumference | 1.03 | 1.00–1.06 | 0.009 | |||
| Neck circumference | 1.04 | 0.96–1.13 | 0.287 | |||
| WHR ≥0.85 | 1.89 | 1.09–3.29 | 0.024 | |||
| BMI | 1.09 | 1.03–1.16 | 0.002 | |||
| Alopecia | 1.93 | 1.11–3.36 | 0.019 | 3.42 | 1.31–8.94 | 0.017 |
| CVE | 3.55 | 1.22–10.35 | 0.020 | |||
| Metabolic syndrome | 5.27 | 1.33–20.92 | <0.001 | 5.39 | 1.34–21.62 | 0.012 |
| Occupation** | 1.43 | 0.79–2.58 | 0.233 | |||
| Marital status*** | 2.29 | 1.07–4.90 | 0.033 | |||
| HT | 3.20 | 1.63–6.31 | 0.001 | |||
| High FPG | 2.75 | 1.12–6.76 | 0.022 | |||
| Large waist | 3.17 | 1.80–5.58 | <0.001 | |||
| High TG | 3.40 | 1.42–8.18 | 0.004 | |||
| Low HDL | 0.66 | 0.38–1.16 | 0.152 | |||
| Total testosterone | 1.83 | 0.45–7.51 | 0.047 | |||
| Free testosterone | 0.365 | 0.2–0.57 | <0.001 | 0.18 | 0.09–0.37 | <0.001 |
*
statistically significant at p<0.05;
**
unemployed vs. employed;
***
single vs. couple; AGA: androgenetic alopecia; BMI: body mass index; CVE: cardiovascular event; FPG: fasting plasma glucose; FSD: female sexual dysfunction; HDL: high-density lipoprotein; HT: height; TG: triglyceride; WHR: waist-to-hip ratio.